ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Miss Nadia · 0 0 0

Patient basic information Patient: Ms Nadia (Nadia King) Nationality: South Sudan Disease Diagnosis: Lymphoma Diagnostic Hospital: H0 treatment: Intervention treatment + medication treatment Household days: 142 days Treatment cost: about 407069 yuan Treatment effect: Rehabilitation Hospital Description: Ms Nadia is from South Sudan and was diagnosed with lymphoma locally. Following the arrival of the patient, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's inspection reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. After 142 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard.

Treatment results The patient finally recovered from the hospital. At the time of his discharge, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. The patient commented: 'We are impressed by the level of expertise of Chinese doctors and the condition of equipment in Chinese hospitals.

'Mrs. Nadia has been criticized by experts as a typical case of cross-border suspected seriousness in clinical cases. The multi-disciplinary collaborative mechanism for developing interventional therapies and drug therapies for lymphoma reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated.

南苏丹,淋巴瘤,中国人民解放军总医院,国际医疗,来华就医,中国医疗